BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8781541)

  • 1. Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display.
    Tyutyulkova S; Gao QS; Thompson A; Rennard S; Paul S
    Biochim Biophys Acta; 1996 Aug; 1316(3):217-23. PubMed ID: 8781541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic activity of anti-ground state antibodies, antibody subunits, and human autoantibodies.
    Paul S
    Appl Biochem Biotechnol; 1994; 47(2-3):241-53; discussion 253-5. PubMed ID: 7944341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of functional human immunoglobulin light chains from a phage-display library.
    Tyutyulkova S; Paul S
    Appl Biochem Biotechnol; 1994; 47(2-3):191-7; discussion 198. PubMed ID: 7944337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment.
    Paul S; Li L; Kalaga R; Wilkins-Stevens P; Stevens FJ; Solomon A
    J Biol Chem; 1995 Jun; 270(25):15257-61. PubMed ID: 7797511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus: molecular cloning and analysis of recombinant monoclonal kappa light chain NGTA2-Me-pro-ChTr possessing two different activities-trypsin-like and metalloprotease.
    Timofeeva AM; Ivanisenko NV; Buneva VN; Nevinsky GA
    Int Immunol; 2015 Dec; 27(12):633-45. PubMed ID: 26174315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.
    Nishiyama Y; Bhatia G; Bangale Y; Planque S; Mitsuda Y; Taguchi H; Karle S; Paul S
    J Biol Chem; 2004 Feb; 279(9):7877-83. PubMed ID: 14676184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic lupus erythematosus: molecular cloning of several recombinant DNase monoclonal kappa light chains with different catalytic properties.
    Botvinovskaya AV; Kostrikina IA; Buneva VN; Nevinsky GA
    J Mol Recognit; 2013 Oct; 26(10):450-60. PubMed ID: 23996487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of a proteolytic antibody light chain.
    Gao QS; Sun M; Tyutyulkova S; Webster D; Rees A; Tramontano A; Massey RJ; Paul S
    J Biol Chem; 1994 Dec; 269(51):32389-93. PubMed ID: 7798238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic activity of an antibody light chain.
    Sun M; Gao QS; Li L; Paul S
    J Immunol; 1994 Dec; 153(11):5121-6. PubMed ID: 7963569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutagenesis of proteolytic antibody light chain.
    Gao QS; Sun M; Rees AR; Paul S
    J Mol Biol; 1995 Nov; 253(5):658-64. PubMed ID: 7473741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity chromatography of catalytic autoantibody to vasoactive intestinal peptide.
    Paul S; Volle DJ; Mei S
    J Immunol; 1990 Aug; 145(4):1196-9. PubMed ID: 2380555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus: molecular cloning and analysis of recombinant DNase monoclonal κ light chain NGK-1.
    Kostrikina IA; Odintsova ES; Buneva VN; Nevinsky GA
    Int Immunol; 2014 Aug; 26(8):439-50. PubMed ID: 24919596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody.
    Paul S; Volle DJ; Beach CM; Johnson DR; Powell MJ; Massey RJ
    Science; 1989 Jun; 244(4909):1158-62. PubMed ID: 2727702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low level formation of potent catalytic IgG fragments mediated by disulfide bond instability.
    Li L; Sun M; Gao QS; Paul S
    Mol Immunol; 1996; 33(7-8):593-600. PubMed ID: 8760270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-driven formation of a proteolytic antibody light chain.
    Gao QS; Sun M; Tyutyulkova S; Webster D; Rees A; Tramontano A; Massey RJ; Paul S
    Ann N Y Acad Sci; 1995 Sep; 764():567-9. PubMed ID: 7486586
    [No Abstract]   [Full Text] [Related]  

  • 18. Design of a serine protease-like catalytic triad on an antibody light chain displayed on the yeast cell surface.
    Okochi N; Kato-Murai M; Kadonosono T; Ueda M
    Appl Microbiol Biotechnol; 2007 Dec; 77(3):597-603. PubMed ID: 17899065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus: molecular cloning of fourteen recombinant DNase monoclonal kappa light chains with different catalytic properties.
    Kostrikina IA; Buneva VN; Nevinsky GA
    Biochim Biophys Acta; 2014 Jun; 1840(6):1725-37. PubMed ID: 24462577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site specificity of a catalytic vasoactive intestinal peptide antibody. An inhibitory vasoactive intestinal peptide subsequence distant from the scissile peptide bond.
    Paul S; Volle DJ; Powell MJ; Massey RJ
    J Biol Chem; 1990 Jul; 265(20):11910-3. PubMed ID: 2365706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.